Home / Health & Fitness / New Gammora HIV drug kills 99 per cent of virus during first human trial
New Gammora HIV drug

New Gammora HIV drug kills 99 per cent of virus during first human trial

New Gammora HIV drug

New Gammora HIV drug: A new HIV drug created by Israeli researchers has passed its first human clinical trial.

At end of the trial, it was discovered that the drug, named Gammora, created by Zion Medical, an Israeli biotech company was capable of wiping out 99 percent of HIV infected cells in the human body.

According to a statement released by the company and available on PR Newswire, Gammora was able to eliminate up to 90 percent of the virus during the first four weeks of the trial.

Zion Medical developed the drug Gammora in collaboration with the Hebrew University in Jerusalem and the Sirion Biotech in Germany.

The drug is designed to attack and kill the HIV-infected cells in the human body without causing damage to the healthy cells.

In the study, researchers randomly assigned nine participating patients from the Ronald Bata Memorial Hospital in Uganda to receive different doses of Gammora between four to five weeks in July and August of this year.

While the new HIV drug is still in its first stage of exploration, the results have already offered hope that a cure for the dreaded virus is possible.

“Most patients showed a significant reduction of the viral load of up to 90 percent from the baseline during the first four weeks,” said Dr. Esmira Naftalim, Zion Medical’s head of development.

New Gammora HIV drug

Read More About :-

Michael Dertouzos is honoring with a Google doodle

Google Doodle pays tribute to the Michael Dertouzo a computer scientist who predicted smartphones

Kim Kardashians news

taylor swift latest news

American Foot Ball News

aguma drug, gammon drug, gammora cure, gammora drug trials, gammora hiv cure, gammora hiv drug 2018, gammora ingredients, gammora price, gamora medicine, gommora drug, gomora drug, gomorrah drug, new hiv drug 2018, quackery meaning,

Loading...